Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Anaemia | 11% - 32% | x | |
Nausea | 1% - 42% | x | |
Fatigue | 5% - 37% | x | |
Body temperature increased | 2% - 35% | x | |
Vomiting | 1% - 29% | x | |
Dyspnoea | 6% - 22% | x | |
Diarrhoea | 2% - 23% | x | |
Constipation | 1% - 23% | x | |
Thrombocytopenia | 7% - 16% | x | |
Rash | 1% - 20% | x | |
Oedema peripheral | 0% - 20% | x | |
Cough | 0% - 19% | x | |
Pruritus | 3% - 16% | x | |
Hyperlactacidaemia | 2% - 16% | x | |
Chills | 1% - 16% | x | |
Decreased appetite | 2% - 15% | x | |
Hypokalaemia | 4% - 12% | x | |
Headache | 0% - 15% | x | |
Electrocardiogram QT prolonged | 4% - 11% | x | |
Infusion site pain | 0% - 14% | x | |
Hypotension | 3% - 10% | x | |
Abdominal pain | 1% - 11% | x | |
Phlebitis | 1% - 10% | x | |
Dizziness | 0% - 10% | x | |
Neoplasm malignant | x | ||
Infection | x | ||
Multi-organ failure | x | ||
Pneumonia | x | ||
Tumour lysis syndrome | x | ||
Ventricular fibrillation | x | ||
Hepatic failure | x | ||
Creatinine increased | x | ||
Hepatotoxicity | x | ||
Febrile neutropenia | x | ||
Electrocardiogram QT corrected interval prolonged | x | ||
Gastrointestinal toxicity | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |